id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2005-P-0196-0056,FDA,FDA-2005-P-0196,FDA Final Response to CSPI on Sodium - 2016-06-01,Other,Denial of Petition,2016-06-01T04:00:00Z,2016,6,2016-06-01T04:00:00Z,,2016-06-01T13:58:24Z,,0,0,0900006482004f23
FDA-2005-P-0196-0050,FDA,FDA-2005-P-0196,Letter from Michael M. Landa to FDA CFSAN,Other,Letter(s),2016-05-26T04:00:00Z,2016,5,2016-05-26T04:00:00Z,,2016-05-26T12:55:32Z,,0,0,0900006481ce9507
FDA-2005-P-0196-0036,FDA,FDA-2005-P-0196,Salt and Sodium; Petition to Revise the Regulatory Status of Salt and Establish Food Labeling Requirements Regarding Salt and Sodium; Public Hearing; Request for Comments,Notice,Notice of Opportunity of Hearing,2016-05-25T04:00:00Z,2016,5,2016-05-25T04:00:00Z,,2016-05-25T19:28:34Z,,0,0,0900006481ff0856